{"id":196385,"date":"2026-08-11T12:19:29","date_gmt":"2026-08-11T06:49:29","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=196385"},"modified":"2026-08-11T12:19:30","modified_gmt":"2026-08-11T06:49:30","slug":"lotus-eye-care-q1-results-fy27-pat-0-61-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/lotus-eye-care-q1-results-fy27-pat-0-61-crore\/","title":{"rendered":"Lotus Eye Care Q1 FY27 Results: Revenue Rs 17 Cr, PAT Rs 0.61 Cr and Key Highlights"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Lotus Eye Care Q1 FY27: Revenue Rs 17 Cr (+26.19% YoY). PAT Rs 0.61 Cr (+12.65% YoY). Results announced Aug 10, 2026. CMP Rs 115.61.<\/em><\/p>\n<p>Lotus Eye Care Q1 FY27 results were announced on August 10, 2026, with the healthcare and eye care company reporting a net profit (PAT) of Rs 0.61 crore, up 12.65% from Rs 0.54 crore in Q1 FY26. Revenue from operations in the Lotus Eye Care Q1 FY27 results rose 26.19% year on year to Rs 17 crore from Rs 13 crore in Q1 FY26. These Lotus Eye Care Q1 FY27 results are on a standalone basis for the quarter ended June 30, 2026.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=lotus-eye-care-q1-results-fy27-pat-0-61-crore\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/lotus-eye-care-q1-results-fy27-pat-0-61-crore\/#Lotus_Eye_Care_Q1_FY27_Financial_Highlights\" title=\"Lotus Eye Care Q1 FY27 Financial Highlights\">Lotus Eye Care Q1 FY27 Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/lotus-eye-care-q1-results-fy27-pat-0-61-crore\/#Lotus_Eye_Care_Q1_FY27_Performance_Analysis\" title=\"Lotus Eye Care Q1 FY27 Performance Analysis\">Lotus Eye Care Q1 FY27 Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/lotus-eye-care-q1-results-fy27-pat-0-61-crore\/#Key_Business_Factors_in_Lotus_Eye_Care_Q1_FY27\" title=\"Key Business Factors in Lotus Eye Care Q1 FY27\">Key Business Factors in Lotus Eye Care Q1 FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/lotus-eye-care-q1-results-fy27-pat-0-61-crore\/#1_Revenue_Growth_Drove_Top-Line_Expansion\" title=\"1. Revenue Growth Drove Top-Line Expansion\">1. Revenue Growth Drove Top-Line Expansion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/lotus-eye-care-q1-results-fy27-pat-0-61-crore\/#2_Gross_Profit_Momentum_Supported_Margins\" title=\"2. Gross Profit Momentum Supported Margins\">2. Gross Profit Momentum Supported Margins<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/lotus-eye-care-q1-results-fy27-pat-0-61-crore\/#3_Net_Profit_Improvement_in_Q1_FY27\" title=\"3. Net Profit Improvement in Q1 FY27\">3. Net Profit Improvement in Q1 FY27<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/lotus-eye-care-q1-results-fy27-pat-0-61-crore\/#Dividend_Details\" title=\"Dividend Details\">Dividend Details<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/lotus-eye-care-q1-results-fy27-pat-0-61-crore\/#Lotus_Eye_Care_FY27_Outlook_After_Q1_Results\" title=\"Lotus Eye Care FY27 Outlook After Q1 Results\">Lotus Eye Care FY27 Outlook After Q1 Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/lotus-eye-care-q1-results-fy27-pat-0-61-crore\/#Lotus_Eye_Care_Stock_Performance\" title=\"Lotus Eye Care Stock Performance\">Lotus Eye Care Stock Performance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/lotus-eye-care-q1-results-fy27-pat-0-61-crore\/#Key_Risks_to_Watch_After_Lotus_Eye_Care_Q1_FY27_Results\" title=\"Key Risks to Watch After Lotus Eye Care Q1 FY27 Results\">Key Risks to Watch After Lotus Eye Care Q1 FY27 Results<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/lotus-eye-care-q1-results-fy27-pat-0-61-crore\/#1_Sector-Specific_Demand_Headwinds\" title=\"1. Sector-Specific Demand Headwinds\">1. Sector-Specific Demand Headwinds<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/lotus-eye-care-q1-results-fy27-pat-0-61-crore\/#2_Input_Cost_and_Margin_Pressure\" title=\"2. Input Cost and Margin Pressure\">2. Input Cost and Margin Pressure<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/lotus-eye-care-q1-results-fy27-pat-0-61-crore\/#3_Macroeconomic_and_Regulatory_Uncertainty\" title=\"3. Macroeconomic and Regulatory Uncertainty\">3. Macroeconomic and Regulatory Uncertainty<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/lotus-eye-care-q1-results-fy27-pat-0-61-crore\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/lotus-eye-care-q1-results-fy27-pat-0-61-crore\/#Frequently_Asked_Questions_on_Lotus_Eye_Care_Q1_FY27_Results\" title=\"Frequently Asked Questions on Lotus Eye Care Q1 FY27 Results\">Frequently Asked Questions on Lotus Eye Care Q1 FY27 Results<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/lotus-eye-care-q1-results-fy27-pat-0-61-crore\/#When_were_the_Lotus_Eye_Care_Q1_FY27_results_announced\" title=\"When were the Lotus Eye Care Q1 FY27 results announced?\">When were the Lotus Eye Care Q1 FY27 results announced?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/lotus-eye-care-q1-results-fy27-pat-0-61-crore\/#What_is_the_PAT_in_the_Lotus_Eye_Care_Q1_FY27_results\" title=\"What is the PAT in the Lotus Eye Care Q1 FY27 results?\">What is the PAT in the Lotus Eye Care Q1 FY27 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/lotus-eye-care-q1-results-fy27-pat-0-61-crore\/#What_was_the_revenue_in_the_Lotus_Eye_Care_Q1_FY27_results\" title=\"What was the revenue in the Lotus Eye Care Q1 FY27 results?\">What was the revenue in the Lotus Eye Care Q1 FY27 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/lotus-eye-care-q1-results-fy27-pat-0-61-crore\/#Did_Lotus_Eye_Care_declare_any_dividend_along_with_Q1_FY27_results\" title=\"Did Lotus Eye Care declare any dividend along with Q1 FY27 results?\">Did Lotus Eye Care declare any dividend along with Q1 FY27 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/lotus-eye-care-q1-results-fy27-pat-0-61-crore\/#What_is_the_Lotus_Eye_Care_outlook_for_FY27_after_Q1_results\" title=\"What is the Lotus Eye Care outlook for FY27 after Q1 results?\">What is the Lotus Eye Care outlook for FY27 after Q1 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/lotus-eye-care-q1-results-fy27-pat-0-61-crore\/#Is_Lotus_Eye_Care_a_good_investment_after_Q1_FY27_results\" title=\"Is Lotus Eye Care a good investment after Q1 FY27 results?\">Is Lotus Eye Care a good investment after Q1 FY27 results?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Lotus_Eye_Care_Q1_FY27_Financial_Highlights\"><\/span><strong>Lotus Eye Care Q1 FY27 Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below presents the key financial metrics from the Lotus Eye Care Q1 FY27 results compared with the corresponding quarter of the previous year.<\/p>\n<table>\n<thead>\n<tr>\n<th>Metric<\/th>\n<th>Q1 FY27 (Jun 2026)<\/th>\n<th>Q1 FY26 (Jun 2025)<\/th>\n<th>YoY Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Revenue from Operations (Rs Cr)<\/td>\n<td>Rs 17 Cr<\/td>\n<td>Rs 13 Cr<\/td>\n<td>+26.19%<\/td>\n<\/tr>\n<tr>\n<td>Gross Profit (Rs Cr)<\/td>\n<td>Rs 1 Cr<\/td>\n<td>Rs 0.66 Cr<\/td>\n<td>+99.24%<\/td>\n<\/tr>\n<tr>\n<td>Net Profit \/ (Loss) &#8211; PAT (Rs Cr)<\/td>\n<td>Rs 0.61 Cr<\/td>\n<td>Rs 0.54 Cr<\/td>\n<td>+12.65%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Lotus_Eye_Care_Q1_FY27_Performance_Analysis\"><\/span><strong>Lotus Eye Care Q1 FY27 Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Use the Univest Screener to Track Live Fundamentals of Indian Stocks<\/strong><\/a><\/p>\n<p>The Lotus Eye Care Q1 FY27 results show revenue growth of 26.19% year on year to Rs 17 crore. Gross profit improved to Rs 1 crore from Rs 0.66 crore in Q1 FY26.<\/p>\n<p>Net profit in the Lotus Eye Care Q1 FY27 results stood at Rs 0.61 crore, up 12.65% from Rs 0.54 crore in Q1 FY26. Investors tracking the Lotus Eye Care Q1 FY27 results should verify these figures against the official BSE and NSE filings for accuracy.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Business_Factors_in_Lotus_Eye_Care_Q1_FY27\"><\/span><strong>Key Business Factors in Lotus Eye Care Q1 FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"1_Revenue_Growth_Drove_Top-Line_Expansion\"><\/span><strong>1. Revenue Growth Drove Top-Line Expansion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Lotus Eye Care Q1 FY27 results show revenue growing 26.19% year on year to Rs 17 crore. The improvement reflects stronger demand or expanded operations within the Healthcare and Eye Care segment during the June 2026 quarter.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_Gross_Profit_Momentum_Supported_Margins\"><\/span><strong>2. Gross Profit Momentum Supported Margins<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Gross profit in the Lotus Eye Care Q1 FY27 results improved to Rs 1 crore from Rs 0.66 crore in Q1 FY26, a gain of 99.24%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_Net_Profit_Improvement_in_Q1_FY27\"><\/span><strong>3. Net Profit Improvement in Q1 FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Lotus Eye Care Q1 FY27 results delivered a net profit (PAT) of Rs 0.61 crore, up 12.65% from Rs 0.54 crore in Q1 FY26. This profit improvement reflects the company&#8217;s improving operational leverage in the Healthcare and Eye Care space.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Dividend_Details\"><\/span><strong>Dividend Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>No dividend has been declared alongside the Lotus Eye Care Q1 FY27 results for the quarter ended June 2026. Investors may track any future dividend announcements via BSE India and NSE India.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Lotus_Eye_Care_FY27_Outlook_After_Q1_Results\"><\/span><strong>Lotus Eye Care FY27 Outlook After Q1 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Lotus Eye Care Q1 FY27 results set a broadly positive tone for the full financial year. Revenue growth of 26.19% and a net profit (PAT) of Rs 0.61 crore provide a foundation for further improvement. Investors tracking the Lotus Eye Care Q1 FY27 results should monitor demand conditions in the Healthcare and Eye Care sector, input cost movements, and any capacity or business expansion plans that could drive earnings through the remainder of FY27.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Lotus_Eye_Care_Stock_Performance\"><\/span><strong>Lotus Eye Care Stock Performance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Lotus Eye Care live share price and upcoming quarterly results.<\/em><\/p>\n<p>Lotus Eye Care share price stood at Rs 115.61 on August 10, 2026, the day the Lotus Eye Care Q1 FY27 results were declared. Post-results, the market will assess whether the Healthcare and Eye Care company&#8217;s financial performance justifies the current valuation. Investors should verify the latest price and fundamentals before making any decision.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Watch_After_Lotus_Eye_Care_Q1_FY27_Results\"><\/span><strong>Key Risks to Watch After Lotus Eye Care Q1 FY27 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"1_Sector-Specific_Demand_Headwinds\"><\/span><strong>1. Sector-Specific Demand Headwinds<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>A slowdown in the Healthcare and Eye Care sector could affect Lotus Eye Care revenue and profitability beyond what the Q1 FY27 results currently indicate.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_Input_Cost_and_Margin_Pressure\"><\/span><strong>2. Input Cost and Margin Pressure<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Rising raw material or operational costs could compress gross margins and limit net profit improvement in subsequent quarters of FY27.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_Macroeconomic_and_Regulatory_Uncertainty\"><\/span><strong>3. Macroeconomic and Regulatory Uncertainty<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Broader macroeconomic headwinds including inflation, interest rate changes, and regulatory shifts remain key risks to the FY27 earnings outlook for Lotus Eye Care.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Lotus Eye Care Q1 FY27 results report revenue of Rs 17 crore and a net profit (PAT) of Rs 0.61 crore, up 12.65% from Rs 0.54 crore in Q1 FY26. The Lotus Eye Care Q1 FY27 results reflect the company&#8217;s operational position in the Healthcare and Eye Care sector for the June 2026 quarter. Investors should study the complete financials available on BSE and NSE and consult a SEBI-registered advisor before making any investment decision.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Lotus_Eye_Care_Q1_FY27_Results\"><\/span><strong>Frequently Asked Questions on Lotus Eye Care Q1 FY27 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"When_were_the_Lotus_Eye_Care_Q1_FY27_results_announced\"><\/span><strong>When were the Lotus Eye Care Q1 FY27 results announced?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Lotus Eye Care Q1 FY27 results were announced on August 10, 2026, covering the quarter ended June 30, 2026. The standalone results were filed with BSE and NSE on the same date.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_PAT_in_the_Lotus_Eye_Care_Q1_FY27_results\"><\/span><strong>What is the PAT in the Lotus Eye Care Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> PAT (net profit) stood at Rs 0.61 crore in the June 2026 quarter, up 12.65% from Rs 0.54 crore in Q1 FY26.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_revenue_in_the_Lotus_Eye_Care_Q1_FY27_results\"><\/span><strong>What was the revenue in the Lotus Eye Care Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue for the June 2026 quarter rose 26.19% year on year to Rs 17 crore from Rs 13 crore in Q1 FY26.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_Lotus_Eye_Care_declare_any_dividend_along_with_Q1_FY27_results\"><\/span><strong>Did Lotus Eye Care declare any dividend along with Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No dividend has been declared with the Lotus Eye Care Q1 FY27 results for the June 2026 quarter. Investors may track future dividend announcements through the BSE and NSE portals.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Lotus_Eye_Care_outlook_for_FY27_after_Q1_results\"><\/span><strong>What is the Lotus Eye Care outlook for FY27 after Q1 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The June 2026 quarter data signals a positive start to FY27 for Lotus Eye Care. Key factors to watch include revenue trends, margin performance, and sector developments through the rest of the financial year.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Lotus_Eye_Care_a_good_investment_after_Q1_FY27_results\"><\/span><strong>Is Lotus Eye Care a good investment after Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Q1 FY27 financial performance of Lotus Eye Care shows improving trends. This article is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered investment advisor before making any investment decision.<\/p>\n<div class=\"faq-schema\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Lotus Eye Care Q1 FY27 results: Revenue Rs 17 Cr, PAT Rs 0.61 Cr. Key highlights, performance analysis and FY27 outlook. Read full results.<\/p>\n","protected":false},"author":36,"featured_media":196384,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-196385","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["196384"],"_edit_lock":["1786430973:36"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["81"],"rank_math_title":["Lotus Eye Care Q1 FY27 Results: PAT Rs 0.61 Cr, Revenue Rs 17 Cr"],"rank_math_description":["Lotus Eye Care Q1 FY27 results: Revenue Rs 17 Cr, PAT Rs 0.61 Cr. Key highlights, performance analysis and FY27 outlook. Read full results."],"rank_math_focus_keyword":["Lotus Eye Care Q1"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_edit_last":["36"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["35814"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/lotus-eye-care-q1-results-fy27-pat-0-61-crore.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/196385","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/36"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=196385"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/196385\/revisions"}],"predecessor-version":[{"id":196428,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/196385\/revisions\/196428"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/196384"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=196385"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=196385"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=196385"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}